Publication Date 01/07/2014         Volume. 6 No. 6   
Information to Pharmacists

Editorial

From the desk of the editor

Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.

read more
open full screen

Recent Comments

Click here to read...

Court Rules on Pharmacy Ownership

Staff Writer

articles by this author...

Editing and Researching news and stories about global and local Pharmacy Issues

In a landmark case, the European Court of Justice has upheld laws limiting ownership of pharmacies to pharmacists.
This is a significant blow to the proponents of deregulation and ownership of pharmacies by large retail chains, and the ruling will bolster arguments for retaining similar restrictions in Australia, where deregulation is to be reviewed in 2010.
The explanation of the court's decision, handed down in May 2009, is compellingly simple:

“Unlike pharmacists, non-pharmacists by definition lack training, experience and responsibility” and “do not provide the same safeguards as pharmacists."

This decision provides clarity and allows for better planning by European pharmacists.
The story was reported on the Bloomberg.com site.

open this article full screen


"Europe’s largest drug wholesaler (Celesio), lost a bid to have a European court overturn rules in Germany and Italy that prevent it from owning pharmacies.

The European Court of Justice in Luxembourg said today it’s up to each of the EU’s 27 nations to “determine the level of protection of public health.” The EU’s highest court ruled Italian and German laws that allow only licensed pharmacists to own pharmacies are justified because they ensure drug distribution is reliable and of good quality. Celesio fell 15 percent in Frankfurt trading.

“This is bad for Celesio, but it’s not a catastrophe, they still have other good growth opportunities,” Karl-Heinz Scheunemann, an analyst at Landesbank Baden-Wuerttemberg in Stuttgart, Germany, said in an interview today. “We had hoped the decision could be a bit different.”

"The court’s ruling today could have opened Germany’s 37 billion-euro ($50 billion) pharmacy business to Celesio. At stake were similar bans in at least 10 other EU countries, including Austria, France and Spain."

“Unlike pharmacists, non-pharmacists by definition lack training, experience and responsibility” and “do not provide the same safeguards as pharmacists,” the court said today.Building up pharmacy chains in Germany and Italy “is far out of reach now,” Thomas Maul, an analyst at DZ Bank AG in Frankfurt, said in a note to clients today. “Pharmacy deregulation in Germany was an essential part of Celesio’s ‘equity story’ over the last years. The ‘equity story’ has vanished now.”

Celesio became involved in the EU case after it bought mail-order company DocMorris in 2007. DocMorris, in a 2006 suit by a German pharmacy trade group, was accused of violating a rule that restricts ownership of retail operations to licensed druggists when it opened a shop in the state of Saarland.

Celesio and DocMorris will now focus on expanding the brand partner and mail-order businesses, Oesterle said."

For the full story visit http://www.bloomberg.com/apps/news?pid=20601092&sid=aQzjC7i6b89k&refer=italy

Return to home

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
This question is for testing whether you are a genuine visitor, to prevent automated spam submissions.
Incorrect please try again
Enter the words above: Enter the numbers you hear:

Clinical Newsfeed

health news headlines provided courtesy of Medical News Today.

Click here to read more...

If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.

Subscribe to our mailing list

Email Format
 

 

  • Copyright (C) 2000-2014 Computachem Services, All Rights Reserved.

Website by Ablecode